| Followers | 18 |
| Posts | 8573 |
| Boards Moderated | 0 |
| Alias Born | 01/16/2026 |
Tuesday, February 03, 2026 4:45:02 PM
Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026
February 3, 2026 4:34 PM
PR Newswire (US)
PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
In addition, Viatris will host an Investor Event on March 19, 2026, in New York City. More details regarding the event will be provided during the Company's February investor call.
Analysts and institutional investors will be invited to pre-register for the event and attend through an invite that will be distributed separately. Interested parties will also be able to access a live webcast of the event at investor.viatris.com. A replay of the webcast also will be available on the website.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and
Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026-and-host-investor-event-on-march-19-2026-302678203.html
SOURCE Viatris Inc.
Recent VTRS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:04:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 11:03:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 12:00:16 AM
- Viatris tops forecasts as earnings and revenue beat expectations • IH Market News • 02/26/2026 02:45:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 12:52:59 PM
- Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 02/26/2026 11:59:00 AM
- Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend • PR Newswire (US) • 02/26/2026 11:55:00 AM
- FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia • PR Newswire (US) • 02/25/2026 11:59:00 AM
- Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026 • PR Newswire (US) • 02/03/2026 09:34:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/03/2026 09:30:31 PM
- Viatris Appoints Matthew J. Maletta as Chief Legal Officer • PR Newswire (US) • 02/03/2026 01:30:00 PM
- Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure • PR Newswire (US) • 01/20/2026 11:59:00 AM
- Viatris Appoints Lara Ramsburg as Chief People and Corporate Affairs Officer • PR Newswire (US) • 01/08/2026 02:05:00 PM
- Viatris Provides Pipeline Update on Four Regulatory Milestones • PR Newswire (US) • 12/18/2025 11:59:00 AM
- Viatris to Present at the 44th Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/17/2025 11:59:00 AM
- Viatris Recognized as 2025 Best Workplaces™ in Ontario and for Giving Back • PR Newswire (Canada) • 12/15/2025 02:00:00 PM
- Viatris reconnue comme l'un des meilleurs lieux de travail en Ontario et pour son engagement communautaire en 2025 • PR Newswire (Canada) • 12/15/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 12:00:47 PM
- Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited • PR Newswire (US) • 12/06/2025 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 09:18:44 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/05/2025 09:15:41 PM
- Viatris to Participate in Upcoming Investor Conferences • PR Newswire (US) • 11/24/2025 01:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM

